[{"Assets_0_Q3_USD":281805000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-134199000.0,"NetIncomeLoss_1_Q3_USD":-27058000.0,"NetIncomeLoss_3_Q3_USD":-130070000.0,"StockholdersEquity_0_Q3_USD":251911000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191105"}]